CULLINAN THERAPEUTICS, INC. (CGEM)
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Greenland Energy Company Issues Shareholder Letter Providing Update with Greenlandic Authorities and Regulators and Preparations Occurring at the Jameson Land Basin
Sharon AI Reports Second Quarter 2026 Results
Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026
Papa Johns Announces Second Quarter 2026 Financial Results
Federal Realty Announces Proposed Private Placement of $400 Million of Exchangeable Senior Notes
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
Smith Douglas Homes Reports Second Quarter 2026 Results
Zoetis Announces Second Quarter 2026 Results
Bentley Systems Announces Second Quarter 2026 Results
Xeris Biopharma Reports Second Quarter 2026 Financial Results
PENN Entertainment, Inc. Reports Second Quarter Results
Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias
Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer
Assured Guaranty Ltd. Declares Quarterly Dividend of $0.38 per Common Share